What Next for Cancer Treatment and the NHS? | IPT
Chair: Taiwo Owatemi MP, Health & Social Care Select Committee
Speaker: Faisal Mehmud, UK/Ireland Country Medical Director, Bristol Myers Squibb
Virtual Event

Date:

Tuesday 15 September 2020

Venue:

This is an online event

Start Time:

08:30

End Time:

09:30

Almost one in two people will be diagnosed with cancer at some point in their life. The NHS Long-Term Plan aims to improve cancer care in the UK by providing all patients with a definitive diagnosis within 28 days by the end of 2020. To achieve that, the NHS is rolling out new Rapid Diagnostic Assessment centres. Further plans include creating simpler, standardised clinical trial processes and fast-tracking new products into the NHS. During the coronavirus crisis patients starting cancer treatment remained at 96% of previous levels, however cancer screening was stopped as COVID-19 became the focus of the overwhelming majority of capacity. Better understanding of cancer leads to developing more targeted and sophisticated treatments, such as the Nobel Prize for Medicine 2018 winning discovery of cancer immunotherapy. How can government, industry and the third sector work together to ensure that patients in the UK are able to benefit from new breakthroughs whilst managing the NHS back to a more usual service?

This breakfast meeting will:

  • Consider how the UK compares to other nations in cancer survival rates.
  • Explore the potential impact of cancer immunotherapy for patients and the NHS.
  • Discuss the impact of new technologies in allowing for early diagnosis and personalised treatments, including the workforce skills required for research and treatment.